Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antimalarial drug discovery: progress and approaches
Jair L. Siqueira-Neto, Kathryn J. Wicht, Kelly Chibale, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 10, pp. 807-826
Open Access | Times Cited: 73

Showing 1-25 of 73 citing articles:

Emerging Drug Targets for Antimalarial Drug Discovery: Validation and Insights into Molecular Mechanisms of Function
Peter Mubanga Cheuka, Paul M. Njaria, Godfrey Mayoka, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 2, pp. 838-863
Closed Access | Times Cited: 6
AN EMERGING ERA IN DRUG DELIVERY SYSTEM FOR TREATMENT OF MALARIA: WAVE FROM CONVENTIONAL TO ADVANCED TECHNOLOGY
TAMNNA SHARMA, Abhishek Sharma
International Journal of Applied Pharmaceutics (2025), pp. 48-58
Open Access
Structural comparison of human and Plasmodium proteasome β5 subunits: informing selective inhibitor design for anti-malaria agents
Muhammad Yasir, Jin‐Young Park, Eun‐Taek Han, et al.
Malaria Journal (2025) Vol. 24, Iss. 1
Open Access
Endophytic Fungal Terpenoids: Biosynthesis and Biological Activity
Juan M. Galindo-Solís, Francisco J. Fernández
(2025), pp. 261-299
Closed Access
High-throughput virtual screening and empirical validation of probable inhibitors of Plasmodium falciparum and vivax glutathione transferase using bromosulfophthalein as the benchmark ligand
Olalekan Onisuru, Ikechukwu Achilonu
International Journal of Biological Macromolecules (2025), pp. 140526-140526
Closed Access
Umbelliferone and Its Synthetic Derivatives as Suitable Molecules for the Development of Agents with Biological Activities: A Review of Their Pharmacological and Therapeutic Potential
Anita Kornicka, Łukasz Balewski, Monika Lahutta, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 12, pp. 1732-1732
Open Access | Times Cited: 15
Plasmodium falciparum Mitochondrial Complex III, the Target of Atovaquone, Is Essential for Progression to the Transmissible Sexual Stages
Pradeep Kumar Sheokand, Sabyasachi Pradhan, Andrew E. Maclean, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9239-9239
Open Access | Times Cited: 5
Hybrid Peptide-Alkoxyamine Drugs: A Strategy for the Development of a New Family of Antiplasmodial Drugs
Ange W. Embo-Ibouanga, Michel Nguyen, Lucie Paloque, et al.
Molecules (2024) Vol. 29, Iss. 6, pp. 1397-1397
Open Access | Times Cited: 4
Plasmodium falciparummitochondrial complex III, the target of atovaquone, is essential for progression to the transmissible sexual stages
Pradeep Kumar Sheokand, Alexander Mühleip, Lilach Sheiner
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Multi-criteria decision analysis method for differential diagnosis of tropical febrile diseases
Daniel Asuquo, Kingsley Attai, Ekemini A. Johnson, et al.
Health Informatics Journal (2024) Vol. 30, Iss. 2
Open Access | Times Cited: 3
Towards next-generation treatment options to combat Plasmodium falciparum malaria
John Okombo, David A. Fidock
Nature Reviews Microbiology (2024)
Closed Access | Times Cited: 3
Recent Advances in the Treatment of Malaria
Jawaher M. Alghamdi, Arwa A. Al-Qahtani, Fatimah S. Alhamlan, et al.
Pharmaceutics (2024) Vol. 16, Iss. 11, pp. 1416-1416
Open Access | Times Cited: 3
Differential effects of translation inhibitors onPlasmodium bergheiliver stage parasites
James L. McLellan, Kirsten K. Hanson
Life Science Alliance (2024) Vol. 7, Iss. 6, pp. e202302540-e202302540
Open Access | Times Cited: 2
Characterizing the blood stage antimalarial activity of pyronaridine in healthy volunteers experimentally infected with Plasmodium falciparum
Bridget E. Barber, Rebecca Webster, Adam J. Potter, et al.
International Journal of Antimicrobial Agents (2024) Vol. 64, Iss. 1, pp. 107196-107196
Open Access | Times Cited: 2
Sonochemical synthesis and characterization of Fe(II) and Cu(II) nano-sized complexes of sulfamethoxazole
B. C. Asogwa, I. E. Otuokere
Journal of the Nigerian Society of Physical Sciences (2024), pp. 2011-2011
Open Access | Times Cited: 2
Antimalarial Delivery with a Ferritin-Based Protein Cage: A Step toward Developing Smart Therapeutics against Malaria
Shruti Bhatt, Subrata Dasgupta, Chiging Tupe, et al.
Biochemistry (2024) Vol. 63, Iss. 14, pp. 1738-1751
Closed Access | Times Cited: 2
Optimization of pyrazolopyridine 4-carboxamides with potent antimalarial activity for which resistance is associated with the P. falciparum transporter ABCI3
Petar P. S. Calic, Trent D. Ashton, Mahta Mansouri, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116677-116677
Open Access | Times Cited: 2
Identification of potent and reversible piperidine carboxamides that are species-selective orally active proteasome inhibitors to treat malaria
Aloysus K. Lawong, Suraksha Gahalawat, S. Ray, et al.
Cell chemical biology (2024) Vol. 31, Iss. 8, pp. 1503-1517.e19
Closed Access | Times Cited: 2
Enhancing the Intrinsic Antiplasmodial Activity and Improving the Stability and Selectivity of a Tunable Peptide Scaffold Derived from Human Platelet Factor 4
Nicole Lawrence, Thomas N. G. Handley, Simon J. de Veer, et al.
ACS Infectious Diseases (2024) Vol. 10, Iss. 8, pp. 2899-2912
Open Access | Times Cited: 2
Systematic in vitro evolution in Plasmodium falciparum reveals key determinants of drug resistance
Madeline R. Luth, Karla P. Godinez‐Macias, Daisy Chen, et al.
Science (2024) Vol. 386, Iss. 6725
Open Access | Times Cited: 2
Selective Bias Virtual Screening for Discovery of Promising Antimalarial Candidates targeting Plasmodium N-Myristoyltransferase
Carolina Horta Andrade, Bruna Katiele de Paula Sousa, Sunniva Sigurdardóttir, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Recent advances on patents of Plasmodium falciparum dihydroorotate dehydrogenase ( Pf DHODH) inhibitors as antimalarial agents
Pinky Gehlot, Vivek K. Vyas
Expert Opinion on Therapeutic Patents (2023) Vol. 33, Iss. 9, pp. 579-596
Closed Access | Times Cited: 5
Disclosure of cinnamic acid/4,9-diaminoacridine conjugates as multi-stage antiplasmodial hits
Mélanie Fonte, Catarina Rôla, Sofia Santana, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 104, pp. 117714-117714
Open Access | Times Cited: 1
Targeting PfCLK3 with Covalent Inhibitors: A Novel Strategy for Malaria Treatment
Andrew G. Jamieson, Skye B. Brettell, Omar Jahna, et al.
(2024)
Open Access | Times Cited: 1
What is needed to achieve effective and sustainable control of African animal trypanosomosis?
Liam J. Morrison, Michael P. Barrett, Pieter C. Steketee, et al.
Trends in Parasitology (2024) Vol. 40, Iss. 8, pp. 679-686
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top